This first column of "Drug Discovery" chronicles the development of the drug discovery process and explains how separation technologies fit in the world of drug discovery.
LCGC 18(1), 42–44 (2000).Characterization of Product Related Variants in Therapeutic Monoclonal Antibodies
July 16th 2024Navin Rauniyar and Xuemei Han of Tanvex Biopharma USA recently discussed how identifying product-related variants through characterization enables the recognition of impurities that compromise the quality and safety of drugs.